NearWave Scanner Research Edition
Research Use Only (Tissue Oximetry & Metabolic Imaging)
Pre-clinicalActive
Key Facts
Indication
Research Use Only (Tissue Oximetry & Metabolic Imaging)
Phase
Pre-clinical
Status
Active
Company
About NearWave
NearWave is a private, pre-revenue diagnostics company founded in 2018, commercializing a compact, handheld fdNIRS scanner for deep tissue metabolic imaging. Its core innovation is miniaturizing a complex optical technique into a portable, battery-powered device with a real-time iOS display, targeting both clinical research and future diagnostic applications. The company has secured investment from entities like Cancer Fund Impact Investments and is engaging with academic and hospital partners to validate its technology across potential use cases in sports medicine, cardiovascular health, and oncology.
View full company profile